Appointing an EU Authorized Representative is the most important step for IVD or medical device manufacturers established outside the European Union wanting to enter this market. The Authorized Representative is a manufacturer’s regulatory representative within the EU. Their role goes far beyond providing a European address.
They verify regulatory documentation, support EUDAMED registration, cooperate with competent authorities, and handle compliance issues. It means they carry significant legal responsibilities. In this guide, let’s break down who needs one, what exactly they do, and how manufacturers should choose one.
Who is an EU Authorized Representative?
A European Authorized Representative is an EU-based person or company formally appointed by a manufacturer located outside the EU. This appointment must be made in writing. Once designated, the Authorized Representative acts as the manufacturer’s legal point of contact for EU regulatory matters under MDR or IVDR.
You may see different terms used for this role. These include the following:
- EC REP – European Community Representative
- EU REP – EU Representative
- EUAR – EU Authorized Representative
- EAR – European Authorized Representative
In practice, they all refer to the same requirement. Without an Authorized Representative in place, Notified Bodies will not issue a CE certificate, and devices may be stopped at the EU border.
EU law also requires each Authorized Representative to have access to regulatory expertise. Article 15 of MDR 2017/745 states that an EAR must have a Person Responsible for Regulatory Compliance available on a permanent and continuous basis.
Obligations & Responsibilities of an EAR
The responsibilities of an EU Authorized Representative are principally established under Article 11 of the MDR and IVDR, with the specific tasks defined through the written mandate. Here is what those responsibilities mean practically for a non-EU manufacturer:
| EU AR Responsibility | What It Means |
| Verify regulatory documentation |
Ensure that you’ve drawn up an EU Declaration of Conformity and technical documents
|
| Check applicable certification |
Verify, where applicable, that the appropriate conformity assessment procedure has been carried out
|
| Maintain regulatory access |
Keep specified documentation available for competent authorities.
|
| Support registration obligations |
Comply with applicable registration requirements
|
| Handle authority requests |
Respond to Competent Authority requests for information and documentation
|
| Support corrective actions |
Cooperate with authorities regarding preventive or corrective actions
|
| Communicate complaints |
Inform manufacturers about complaints and reports received from healthcare professionals, patients and users
|
| Monitor manufacturer compliance |
Terminate the legal relationship if the manufacturer acts contrary to its obligations under the regulation.
|
That’s how an Authorized Representative acts as much more than a mailbox between the manufacturer and Europe. Its role also continues throughout the device’s regulatory lifecycle.
What Cannot Be Delegated to an EC REP?
Appointing an EU AR does not transfer the manufacturer’s fundamental responsibility for the device. Certain manufacturer obligations cannot form part of the Authorized Representative’s mandate under MDR Article 11. The manufacturer remains responsible for fundamental areas such as the following:
- Device design and manufacturing compliance
- Risk management
- Quality management
- Clinical evaluation and applicable post-market clinical follow-up
- Technical documentation
- Conformity assessment
- EU Declaration of Conformity
- Meeting other applicable manufacturer obligations under Article 10.
That is one reason manufacturers should establish robust internal MDR/IVDR compliance before approaching European market entry as a representation exercise.
Legal Liability of an Authorized Representative for your Medical Device
A reputable Authorized Representative is unlikely to accept a manufacturer without performing appropriate due diligence. They may want to understand your:
Device portfolio → Conformity status → Technical documentation → Quality systems → Certificates → Post-market processes → Overall regulatory readiness
So, if an EU AR asks difficult compliance questions before accepting your mandate, that’s not necessarily unnecessary for paperwork. They are taking on genuine regulatory responsibilities.
2026 Update: EU Authorized Representatives and EUDAMED
EUDAMED is the European Database on Medical Devices, designed to improve transparency, traceability, and coordination across the EU medical-device system. After the Commission’s November 2025 decision that declared several electronic systems functional, the first four EUDAMED modules became compulsory to use from May 28, 2026. These are given as follows:
- Actor Registration
- UDI/Device Registration
- Notified Bodies & Certificates
- Market Surveillance
That means EUDAMED is no longer something manufacturers and representatives can simply treat as a future compliance project. It is part of today’s EU regulatory environment.
EU Authorized Representative and EUDAMED Actor Registration
Economic operators, including EU and non-EU manufacturers, Authorized Representatives, system/procedure pack producers, and importers, must register as actors in EUDAMED before placing devices or systems/procedure packs on the EU market.
The Actor Registration Module enables economic operators to obtain an Actor ID/Single Registration Number (SRN). There is an additional requirement specifically relevant to overseas manufacturers. A non-EU manufacturer must have an active Authorized Representative and submit a mandate summary document with its EUDAMED registration request.
Hence, manufacturers planning European market entry in 2026 should plan the EU AR and EUDAMED strategies together rather than handling them as unrelated tasks.
Distributor vs. Independent EU AR
Manufacturers sometimes consider appointing their European distributor as their Authorized Representative. The vital strategic conditions for a possible arrangement where all applicable regulatory requirements are satisfied are as follows:
| Distributor as EU AR | Independent EC REP |
|
|
How to Choose the Right EU REP?
Not all representation arrangements offer the same level of regulatory support. So, consider the following questions:
1. MDR and IVDR Expertise
Does the organization understand the regulatory framework applicable to your particular device?
2. PRRC Capability
Does the Authorized Representative have the regulatory expertise required under the applicable legislation?
3. EUDAMED Readiness
Can the representative effectively support current EUDAMED requirements and actor-registration responsibilities?
4. Competent Authority Communication
How will regulatory requests from European authorities be handled and escalated?
5. Post-Market Support
Does the representative have established processes for complaints, vigilance-related communication, and corrective actions?
6. Technical Documentation Security
Your representative may need access to highly confidential regulatory documentation. Understand how that information will be stored, protected, and accessed.
7. Independence
Consider whether commercial relationships could interfere with regulatory neutrality.
8. Transition Arrangements
What happens to records, communications, and regulatory responsibilities if you eventually change representatives?
How to Appoint an EUAR?
The exact process depends on the manufacturer and device portfolio, but the appointment can generally be approached through the following stages.
Step 1: Confirm the Requirement
Establish whether your organization is considered a non-EU manufacturer requiring an Authorized Representative under MDR or IVDR.
Step 2: Identify a Qualified EU AR
Assess regulatory competence, resources, EU establishment, PRRC arrangements, and experience relevant to your devices.
Step 3: Complete Regulatory Due Diligence
The prospective EU AR may review your documentation and compliance position before accepting the relationship.
Step 4: Define the Device Scope
Determine which devices or generic device groups will be covered by the mandate.
Step 5: Execute the Written Mandate
The designation becomes effective through a mandate accepted in writing by the Authorized Representative. MDR Article 11 requires it to cover at least all devices belonging to the same generic device group.
Step 6: Complete EUDAMED Requirements
Address applicable Actor Registration, SRN, and manufacturer–Authorized Representative linkage requirements.
Step 7: Update Applicable Labelling
Ensure EU AR information appears where required under the applicable MDR/IVDR labeling provisions.
Step 8: Establish Ongoing Communication
Define processes for regulatory requests, complaints, post-market information, and corrective actions.
Your EU AR relationship should therefore be built as an ongoing compliance process instead of a one-time appointment.
EU Authorized Representative Labeling Requirements
Once appointed, your AR also becomes relevant to device labeling. Under the MDR’s General Safety and Performance Requirements, where the manufacturer has its registered place of business outside the Union, the label must contain
- The name of the manufacturer
- The name of its Authorized Representative
- The address of their registered place of business
Manufacturers commonly use the standardized EC REP symbol to clearly identify Authorized Representative information. This information should be considered early when preparing EU-compliant artwork. That’s because changing an EU AR later can trigger label-management implications across multiple SKUs, markets, and existing inventory.
Your representation strategy and labeling strategy are therefore more closely connected than they may initially appear.
Check Out: Medical Devices Regulations in the European Union (EU MDR)
EU AR vs UK Responsible Person vs Swiss Representative
European market access became more fragmented following Brexit and changes in EU-Swiss medical-device arrangements. An EU Authorized Representative should not automatically be assumed to provide representation everywhere in geographical Europe.
| Market | Representative |
| European Union | EU Authorized Representative / EC REP |
| Great Britain | UK Responsible Person (UKRP) |
| Switzerland | Swiss Authorized Representative (CH-REP) |
A service provider may offer representation across multiple jurisdictions if it has the necessary legal presence and capabilities. However, one appointment does not automatically satisfy all three regulatory systems. Thus, manufacturers targeting several European markets should build a coordinated representation strategy instead of assuming their EU mandate covers everything.
Changing Your European Authorized Representative
Article 12 of the MDR addresses changing an Authorized Representative and requires the arrangements between the manufacturer, outgoing representative where practicable, and incoming representative to be clearly defined through an agreement. Important considerations can include the following:
Termination date → Commencement date → Transfer of documents → Manufacturer identification → Labeling updates → Complaint handling → Communication responsibilities
The outgoing representative must also forward certain complaints or reports concerning devices for which it had been designated. Hence, manufacturers considering a change should plan the transition carefully to avoid regulatory gaps.
Conclusion
The regulatory responsibilities attached to the EU AR explain why independence can be valuable. Your Authorized Representative may need to communicate with Competent Authorities, maintain access to regulatory documentation, communicate complaints, cooperate with corrective actions, and act when manufacturer compliance becomes problematic.
A regulatory specialist can approach these responsibilities independently from your product’s sales performance or distributor relationship. For manufacturers operating across multiple EU markets, that separation can provide greater flexibility as the commercial network evolves.
Artixio supports manufacturers with European Authorized Representative and regulatory market access services designed to create a clearer path into the EU market. Ready to enter or strengthen your presence in the European market? Contact Artixio at info@artixio.com to discuss your EU Authorized Representative and medical device compliance consulting services.
FAQs
Who Needs an EU Authorized Representative?
If your medical device or IVD manufacturing company is established outside the European Union and wants to place applicable devices on the EU market, you must designate a sole Authorized Representative established within the EU.
Article 11 of the MDR specifically states that where a device manufacturer is not established in a Member State, the device may only be placed on the Union market after the manufacturer designates a sole Authorized Representative.
Is an EU Authorized Representative mandatory for every non-EU medical device manufacturer?
Where a manufacturer of a device is not established in an EU Member State, MDR Article 11 requires the manufacturer to designate a sole Authorized Representative before the device can be placed on the Union market. Manufacturers should assess the requirements applicable to their particular device and regulatory situation.
Is an EU Authorized Representative the same as a Notified Body?
No. An Authorized Representative performs specified regulatory tasks on behalf of a non-EU manufacturer. A Notified Body is a conformity assessment body involved in evaluating applicable devices where third-party conformity assessment is required.
Does a Class I medical device manufacturer outside the EU need an Authorized Representative?
The Article 11 requirement is linked to the manufacturer’s establishment outside an EU Member State rather than simply being limited to higher-risk device classes. Manufacturers should still assess the specific regulatory status and requirements applicable to their device.
